|Videos|December 22, 2021
Dr. Eggener discusses low-risk prostate cancer treatment options
Author(s)Urology Times staff
“We do have a long way to go across the United States,” says Scott E. Eggener, MD.
Advertisement
In this video, Scott Eggener, MD, discusses how low-risk prostate cancer treatments have evolved and what he hopes the future holds for this group of patients, which were topics focused on at the 2021 Society of Urological Oncology Annual Meeting. Eggener is a Bruce and Beth White Family professor of surgery and radiology, vice chair of the section of urology, and director of the High Risk and Advanced Prostate Cancer Clinic at the University of Chicago Medical Center in Chicago, Illinois.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA provides guidance on development pathway for testosterone therapy for women
2
Treatment Selection in Advanced Prostate Cancer
3
Pearls & Perspectives: Leadership and Prostate Cancer, with Mark L. Gonzalgo, MD, PhD, MBA
4
Annual ACS NCDB report details national trends in prostate cancer care
5